3042 companies

China Animal Husbandry Industry

Market Cap: CN¥7.2b

Researches, develops, produces, and sells animal health and nutrition products in China and internationally.

600195

CN¥7.06

7D

-2.2%

1Y

6.8%

Hunan Er-Kang Pharmaceutical

Market Cap: CN¥7.2b

Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.

300267

CN¥3.49

7D

-4.4%

1Y

38.5%

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

CRON

CA$3.65

7D

1.4%

1Y

25.0%

Shandong Jincheng Pharmaceutical Group

Market Cap: CN¥7.2b

Researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally.

300233

CN¥18.91

7D

-6.3%

1Y

51.0%

Genomma Lab Internacional. de

Market Cap: Mex$18.4b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

LAB B

Mex$18.85

7D

-7.8%

1Y

-15.8%

Shandong Boan Biotechnology

Market Cap: HK$7.8b

A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.

6955

HK$12.54

7D

-10.2%

1Y

29.3%

YD Bio

Market Cap: US$1.0b

A biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.

YDES

US$16.00

7D

-19.1%

1Y

42.1%

Jiangsu Jibeier Pharmaceutical

Market Cap: CN¥7.1b

A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.

688566

CN¥35.40

7D

-1.8%

1Y

60.9%

Towa Pharmaceutical

Market Cap: JP¥147.7b

Manufactures and sale ethical drugs in Japan.

4553

JP¥3,000.00

7D

0.9%

1Y

-2.1%

Hainan Haiyao

Market Cap: CN¥7.0b

Manufactures and sells pharmaceutical products and medical devices in China and internationally.

000566

CN¥5.40

7D

-8.2%

1Y

37.4%

PolyPeptide Group

Market Cap: CHF 781.9m

Operates as a contract development and manufacturing company in Europe, the United States, and India.

PPGN

CHF 23.70

7D

-7.8%

1Y

-25.4%

Maccura BiotechnologyLtd

Market Cap: CN¥7.0b

Engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally.

300463

CN¥11.57

7D

-1.8%

1Y

-10.0%

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥7.0b

Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.

002437

CN¥3.11

7D

-7.4%

1Y

51.0%

Gubra

Market Cap: DKK 6.2b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

GUBRA

DKK 381.20

7D

-10.5%

1Y

-21.7%

Kaken Pharmaceutical

Market Cap: JP¥146.2b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

4521

JP¥3,860.00

7D

0%

1Y

0.3%

Shouyao Holdings (Beijing)

Market Cap: CN¥6.9b

Engages in the research, development, and production of pharmaceutical drugs in China.

688197

CN¥46.22

7D

0.7%

1Y

35.5%

Idorsia

Market Cap: CHF 763.0m

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.

IDIA

CHF 3.65

7D

-9.6%

1Y

128.0%

Chongqing Pharscin Pharmaceutical

Market Cap: CN¥6.8b

Chongqing Pharscin Pharmaceutical Co., Ltd.

002907

CN¥16.29

7D

-2.6%

1Y

25.4%

Wanbangde Pharmaceutical Holding Group

Market Cap: CN¥6.8b

Wanbangde Pharmaceutical Holding Group Co., Ltd.

002082

CN¥11.08

7D

-2.1%

1Y

143.5%

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$7.4b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

3613

HK$8.81

7D

-2.1%

1Y

2.4%

Spyre Therapeutics

Market Cap: US$942.9m

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

SYRE

US$16.24

7D

9.1%

1Y

-43.0%

ARS Pharmaceuticals

Market Cap: US$942.8m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

SPRY

US$9.80

7D

0.1%

1Y

-31.6%

Jacobio Pharmaceuticals Group

Market Cap: HK$7.3b

An investment holding company, engages in the in-house discovery and development of oncology therapies.

1167

HK$9.24

7D

-12.7%

1Y

402.2%

Polaris Group

Market Cap: NT$28.6b

Offers biotechnology, drug testing, and contract development and manufacturing services.

6550

NT$37.10

7D

0%

1Y

-32.3%

Shanghai InnoStar Bio-tech

Market Cap: CN¥6.7b

Provides drug research and development services in China and internationally.

688710

CN¥47.39

7D

-3.6%

1Y

78.1%

Saudi Pharmaceutical Industries and Medical Appliances

Market Cap: ر.س3.5b

Develops, manufactures, and markets of medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middles East, Egypt, and Morocco.

2070

ر.س29.10

7D

4.3%

1Y

-14.8%

Nanjing Hicin Pharmaceutical

Market Cap: CN¥6.6b

Engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates.

300584

CN¥55.31

7D

-8.5%

1Y

173.8%

Bide Pharmatech

Market Cap: CN¥6.6b

Engages in the research, development, production, and sale of pharmaceutical products in China.

688073

CN¥76.90

7D

10.0%

1Y

136.1%

NatureCellLtd

Market Cap: ₩1.3t

Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.

A007390

₩20,200.00

7D

-3.6%

1Y

108.0%

Oculis Holding

Market Cap: US$915.9m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

OCS

US$17.63

7D

6.1%

1Y

43.2%

Shanxi Zhendong PharmaceuticalLtd

Market Cap: CN¥6.5b

Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally.

300158

CN¥6.57

7D

-10.7%

1Y

69.3%

Clarity Pharmaceuticals

Market Cap: AU$1.4b

A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.

CU6

AU$3.76

7D

0.5%

1Y

-56.5%

EyePoint Pharmaceuticals

Market Cap: US$909.2m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

EYPT

US$13.90

7D

4.9%

1Y

74.2%

MedCap

Market Cap: SEK 8.5b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

MCAP

SEK 568.00

7D

-6.4%

1Y

12.7%

Guizhou Xinbang Pharmaceutical

Market Cap: CN¥6.5b

Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.

002390

CN¥3.42

7D

-3.1%

1Y

0.6%

Center Laboratories

Market Cap: NT$27.6b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

4123

NT$38.85

7D

-1.6%

1Y

-20.7%

Page 17 of 85